CGEM
Cullinan Therapeutics, Inc. · Healthcare
Director and 10% owner Ansbert Gadicke sold $816K of Cullinan Therapeutics, Inc.
Sold$816,352
$29.50Price
27,669Shares
What CGEM did after the filing
- The stock from Thu, Sep 2 close, $29.67
- −15.7%
- S&P 500, same days
- −1.3%
Measured over 30 trading days, to the Oct 15 close.
Traded Tue, Aug 31. Filed Thu, Sep 2, 1:25 PM ET, during the session. Returns use the Sep 2 close and the Oct 15 close. Not investment advice.